New strategies in cancer chemoprevention by phytochemicals

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 1, 2012, Pages 426-452

  Singh, Madhulika ^a   Singh, Payal ^a   Shukla, Yogeshwer ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Anti carcinogenic; Cancer; Chemoprevention; Phytochemicals; Review

Indexed keywords

3 INDOLEMETHANOL; ALLYL SULFIDE; BROMELAIN; CAPSAICIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; LIMONENE; LUPEOL; LYCOPENE; PLANT MEDICINAL PRODUCT; RESVERATROL; TURMERIC; ANTINEOPLASTIC AGENT;

APPLE; ARTICLE; BERRY; CANCER PREVENTION; CHEMOPROPHYLAXIS; CITRUS FRUIT; GINGER; GRAPE; HUMAN; NONHUMAN; PEANUT; PEPPER; PINEAPPLE; TEA; TOMATO; CHEMISTRY; FOOD; NEOPLASM; PLANT; REVIEW;

ANTICARCINOGENIC AGENTS; FOOD; HUMANS; NEOPLASMS; PLANTS;

EID: 84860847973     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/389     Document Type: Article

References (324)

1. WC Willett: Diet and health: what should we eat. Science 254, 532-537 (1994)
2. WC Willett: Balancing life-style and genomics research for disease prevention. Science 296, 695-698 (2002)
3. MA Gates, SS Tworoger, JL Hecht, I De Vivo, B Rosner, SE Hankinson: A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 121(10), 2225-2232 (2007)
4. National Academy of Sciences, Committee on Diet and Health, National Research Council: Diet and Health: Implications for Reducing Chronic Disease Risk 1989, National Academy Press Washington, DC (1989)
5. National Academy of Sciences, National Research Council: Diet, Nutrition, and Cancer 1982, National Academy Press Washington, DC (1982)
6. RH Liu: Health benefits of fruits and vegetables are from additive and synergistic combination of phytochemicals. Am J Clin Nutr 78, 517S-520S (2003)
7. G Block, B Patterson, A Subar: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18, 1-29 (1992)
8. P Knekt, R Jarvinen, R Seppanen, M Heliovaara, L Teppo, E Pukkala, A Aromaa: Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146, 223-230 (1997)
9. L Le Marchand, SP Murphy, JH Hankin, LR Wilkens, LN Kolonel: Intake of flavonoids and lung cancer. J Natl Cancer Inst 92(2), 154-160 (2000)
10. SP Boyle, VL Dobson, SJ Duthie, JAM Kyle, AR Collins: Absorption and DNA protective effects of flavonoid glycosides from an onion meal. Eur J Nutr 39, 213-223 (2000)
11. J Sun, Y-F Chu, X Wu, RH Liu: Antioxidant and antiproliferative activities of fruits. J Agric Food Chem 50, 7449-7454 (2002)
12. KK Adom, RH Liu: Antioxidant activity of grains. J Agric Food Chem 50, 6182-6187 (2002)
13. KK Adom, ME Sorrells, RH Liu: Phytochemicals and antioxidant activity of wheat varieties. J Agric Food Chem 51, 7825-7834 (2003)
14. MT Goodman, LR Wilkens, JH Hankin, LC Lyu, AH Wu, LN Kolonel: Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146(4), 294-306 (1997)
15. M Zhang, X Xie, AH Lee, CW Binns: Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china. Nutr Cancer 49(2), 125-130 (2004)
16. SK Myung, W Ju, HJ Choi, SC Kim: Korean Meta-Analysis (KORMA) Study Group: Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG 116(13), 1697-705 (2009)
17. J Hickey, A Bartke, T Winters, N Henry, W Banz: Effects of soy protein and soy phytochemicals on mammary tumor development in female transgenic mice over-expressing human pituitary growth hormone. J Med Food 8(4), 556-559 (2005)
18. J Kim: Protective effects of Asian dietary items on cancers - soy and ginseng. Asian Pac J Cancer Prev 9(4), 543-558 (2008)
19. LJ Lu, KE Anderson, JJ Grady, F Kohen, M Nagamani: Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 60(15), 4112-4121(2000)
20. LJ Lu, M Cree, S Josyula, M Nagamani, JJ Grady, KE Anderson: Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res 60(5), 1299-1305 (2000)
21. H Wei, L Wei, K Frenkel, R Bowen, S Barnes: Inhibition of tumor promoter induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20, 1-12 (1993)
22. H Adlercreutz: Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 83(1-5), 113-118 (2002)
23. Z Li, J Li, B Mo, C Hu, H Liu, H Qi, X Wang, J Xu: Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Cell Biol Toxicol 24(5), 401-409 (2008)
24. SJ Su, TM Yeh, HY Lei, NH Chow: The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res 6(1), 230-236 (2000)
25. SJ Su, NH Chow, ML Kung, TC Hung, KL Chang: Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer 45(1), 113-123 (2003)
26. G Gossner, M Choi, L Tan, S Fogoros, KA Griffith, M Kuenker, JR Liu: Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol 105(1), 23-30 (2007)
27. A Hsu, TM Bray, WG Helferich, DR Doerge, E Ho: Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Exp Biol Med (Maywood) 235(1), 90-97 (2010)
28. AV Singh, AA Franke, GL Blackburn, JR Zhou: Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res 66(3), 1851-1858 (2006)
29. Z Li, J Li, B Mo, C Hu, H Liu, H Qi, X Wang, J Xu: Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol In vitro 22(7), 1749-1753 (2008)
30. T Valachovicova, V Slivova, D Sliva: Cellular and physiological effects of soy flavonoids. Mini Rev Med Chem 4(8), 881-887 (2004)
31. T Valachovicova, V Slivova, H Bergman, J Shuherk, D Sliva: Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways. Int J Oncol 25(5), 1389-1395 (2004)
32. K Jawaid, SR Crane, JL Nowers, M Lacey, SA Whitehead: Long-term genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors. J Steroid Biochem Mol Biol [Epub ahead of print] (2010)
33. X Chen, JJ Anderson: Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutr Cancer 41(1-2), 165-171 (2001)
34. LA Solomon, S Ali, S Banerjee, AR Munkarah, RT Morris, FH Sarkar: Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. J Ovarian Res 1(1), 9 (2008)
35. V Singh-Gupta, H Zhang, CK Yunker, Z Ahmad, D Zwier, FH Sarkar, GG Hillman: Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy. Pharm Res 27(6), 1115-1127 (2010)
36. L Rice, R Handayani, Y Cui, T Medrano, V Samedi, H Baker, NJ Szabo, CJ Rosser, S Goodison, KT Shiverick: Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells. J Nutr 137(4), 964-972 (2007)
37. L Yu, GL Blackburn, JR Zhou: Genistein and daidzein down-regulate prostate androgen-regulated transcript-1 (PART-1) gene expression induced by dihydrotestosterone in human prostate LNCaP cancer cells. J Nutr 133(2), 389-392 (2003)
38. AI Constantinou, RG Mehta, A Vaughan: Inhibition of N-methyl-N- nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res 16(6A), 3293-3298 (1996)
39. WB Murrill, NM Brown, JX Zhang, PA Manzolillo, S Barnes, CA Lamartiniere: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17(7), 1451-1457 (1996)
40. JH Peng, JD Zhu, MT Mi, FJ Li, L Cai, JZ Dong, HX Zhang, Y Zhao, RL Xue: Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis. Eur J Cancer Prev 19(2), 110-119 (2010)
41. X Kang, S Jin, Q Zhang: Antitumor and antiangiogenic activity of soy phytoestrogen on 7, 12-dimethylbenz [alpha] anthracene-induced mammary tumors following ovariectomy in Sprague-Dawley rats. J Food Sci 74(7), H237- H242 (2009)
42. JR Zhou, ET Gugger, T Tanaka, Y Guo, GL Blackburn, SK Clinton: Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nut 129(9), 1628-1635 (1999)
43. JR Zhou, L Yu, Y Zhong, RL Nassr, AA Franke, SM Gaston, GL Blackburn: Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate 53(2), 143-153 (2002)
44. A Tyagi, RP Singh, C Agarwal, S Siriwardana, RA Sclafani, R Agarwal: Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26 (11): 1978-1987 (2005)
45. N Ahmad, VM Adhami, F Afaq, DK Feyes, H Mukhtar: Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 7(5), 1466-1473 (2001)
46. S Gao, GZ Liu, Z Wang: Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells. Prostate 59(2), 214-225 (2004)
47. DA Benitez, E Pozo-Guisado, A Alvarez-Barrientos, PM Fernandez-Salguero, EA Castellón: Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer- derived cell lines. J Androl 28(2), 282-293 (2007)
48. AW Jr Opipari, L Tan, AE Boitano, DR Sorenson, A Aurora, JR Liu: Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 64(2), 696-703 (2004)
49. IC Low, ZX Chen, S Pervaiz: Bcl-2 Modulates Resveratrol-induced ROS Production by Regulating Mitochondrial Respiration in Tumor Cells. Antioxid Redox Signal [Epub ahead of print] (2010)
50. MH Aziz, M Nihal, VX Fu, DF Jarrard, N Ahmad: Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther 5(5), 1335-1341 (2006)
51. Z Cao, J Fang, C Xia, X Shi, BH Jiang : trans-3,4,5′- Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 10(15), 5253-5263 (2004)
52. SY Park, KJ Jeong, J Lee, DS Yoon, WS Choi, YK Kim, JW Han, YM Kim, BK Kim, HY Lee: Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. Cancer Lett 258(1), 63-69 (2007)
53. A Kueck, AW Jr Opipari, KA Griffith, L Tan, M Choi, J Huang, H Wahl, JR Liu: Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol 107(3), 450-457 (2007)
54. M Kaneuchi, M Sasaki, Y Tanaka, R Yamamoto, N Sakuragi, R Dahiya: Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF. Int J Oncol 23(4), 1167-1172 (2003)
55. E Sexton, C Van Themsche, K LeBlanc, S Parent, P Lemoine, E Asselin: Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer 5, 45 (2006)
56. JR Stewart, CA O'Brian: Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgenindependent prostate cancer cells with associated isozymeselective PKC alpha inhibition. Invest New Drugs 22(2), 107-117 (2004)
57. H Yu, C Pan, S Zhao, Z Wang, H Zhang, W Wu: Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed Pharmacother 62(6), 366-372 (2008)
58. YA Rezk, SS Balulad, RS Keller, JA Bennett: Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart. Am J Obstet Gynecol 194(5), e23-e26 (2006)
59. S Banerjee, C Bueso-Ramos, BB Aggarwal: Suppression of 7,12-Dimethylbenz(a)anthracene-induced Mammary Carcinogenesis in Rats by Resveratrol. Role of Nuclear Factor-{kappa}B, Cyclooxygenase 2, and Matrix Metalloprotease 9. Cancer Research 62, 4945-4954 (2002)
60. DA Benitez, E Pozo-Guisado, M Clementi, E Castellón, PM Fernandez-Salguero: Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway. Br J Cancer 96(10), 1595-1604 (2007)
61. MH Lee, BY Choi, JK Kundu, YK Shin, HK Na, YJ Surh: Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target.Cancer Res 69(18), 7449-7458 (2009)
62. CE Harper, BB Patel, J Wang, A Arabshahi, IA Eltoum, CA Lamartiniere: Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 28(9), 1946-1953 (2007)
63. A Seeni, S Takahashi, K Takeshita, M Tang, S Sugiura, SY Sato, T Shirai: Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev 9(1), 7-14 (2008)
64. A Bishayee, N Dhir: Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem Biol Interact 179(2-3), 131-144 (2009)
65. A Bishayee, A Waghray, KF Barnes, T Mbimba, D Bhatia, M Chatterjee, AS Darvesh: Suppression of the Inflammatory Cascade is Implicated in Resveratrol Chemoprevention of Experimental Hepatocarcinogenesis. Pharm Res [Epub ahead of print] (2010)
66. M Jang, JM Pezzuto: Cancer chemopreventive activity of resveratrol. Drugs Exp Clin Res 25(2-3), 65-77 (1999)
67. JK Kundu, KS Chun, SO Kim, YJ Surh: Resveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular targets. Biofactors 21(1-4), 33-39 (2004)
68. JK Kundu, YK Shin, SH Kim, YJ Surh: Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis 27(7), 1465-1474 (2006)
69. L Almeida, M Vaz-da-Silva, A Falcão, E Soares, R Costa, AI Loureiro, C Fernandes-Lopes, JF Rocha, T Nunes, L Wright, P Soares-da-Silva: Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res 53 Suppl 1, S7-S15 (2009)
70. CS Muir: Cancer incidence in five continents: Classification. IARC Sci Publ 120, 25-30 (1992)
71. MG Jain, GT Hislop, GR Howe, JD Burch, P Ghadirian: Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer 78, 707-711 (1998)
72. L Jian, LP Xie, AH Lee, CW Binns: Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 108, 130-135 (2004)
73. S Bettuzzi, M Brausi, F Rizzi, G Castagnetti, G Peracchia, A Corti: Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-ofprinciple study. Cancer Res 66(2), 1234-1240 (2006)
74. DA August, JM Landau, D Caputo, J Hong, M Lee, CS Yang: Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiol Biomark Prev 8: 709-713 (1999)
75. VW Setiawan, ZF Zhang, GP Yu, QY Lu, YL Li, ML Lu, MR Wang, CH Guo, SZ Yu, RC Kurtz, CC Hsieh: Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer 92(4), 600-604 (2001)
76. CM Nagle, CM Olsen, CJ Bain, DC Whiteman, AC Green, PM Webb: Tea consumption and risk of ovarian cancer: Cancer Causes Control [Epub ahead of print] (2010)
77. H Fujiki: Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 125, 589-597(1999)
78. J Jankun, SH Selman, R Swiercz, E Skrzypczak-Jankun: Why drinking green tea could prevent cancer. Nature 387, 561 (1997)
79. Z Dong, W Ma, C Huang, CS Yang: Inhibition of tumor promoter-induced activator protein-1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate and the aflavins. Cancer Res 57, 4414-4419 (1997)
80. S Nam, DM Smith, QP Dou: Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 276, 13322-13330 (2001)
81. RL Thangapazham, N Passi, RK Maheshwari: Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther 6(12), 1938-1943 (2007)
82. F Afaq, VM Adhami, N Ahmad, H Mukhtar: Inhibition of ultraviolet B-mediated activation of nuclear factor B in normal human epidermal keratinocytes by green tea constituent (-)-epigallocatechin-3-gallate. Oncogene 22, 1035-1044 (2003)
83. S Gupta, K Hastak, F Afaq, N Ahmad, H Mukhtar: Essential role of caspases in epigallocatechin-3-gallatemediated inhibition of nuclear factor kB and induction of apoptosis. Oncogene 23, 2507-2522 (2004)
84. M Shimizu, A Deguchi, JT Lim, H Moriwaki, L Kopelovich, IB Weinstein: (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11, 2735-2746 (2005)
85. S Ahmed, A Rahman, A Hasnain, M Lalonde, VM Goldberg, TM Haqqi: Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1ß-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 33, 1097-1105 (2002)
86. T Hussain, S Gupta, VM Adhami, H Mukhtar: Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 113, 660-669 (2005)
87. Q Zhang, X Tang, Q Lu, Z Zhang, J Rao, AD Le: Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxiaand serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther 5(5), 1227-1238 (2006)
88. FY Tang, EP Chiang, CJ Shih: Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells. J Nutr Biochem 18(6), 391-399 (2007)
89. YK Lee, TD Shanafelt, ND Bone, AK Strege, DF Jelinek, NE Kay: VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance. Leukemia 19, 513-523 (2005)
90. T Neuhaus, S Pabst, S Stier, AA Weber, K Schrör, A Sachinidis, H Vetter, YD Ko : Inhibition of the vascularendothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate. Eur J Pharmacol 483, 223-227(2004)
91. M Masuda, M Suzui, JT Lim, A Deguchi, JW Soh, IB Weinstein: Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2(6), 350-359 (2002)
92. Y Kushima, K Iida, Y Nagaoka, Y Kawaratani, T Shirahama, M Sakaguchi, K Baba, Y Hara, S Uesato: Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biol Pharm Bull 32(5), 899-904 (2009)
93. YP Lu, YR Lou, XH Li, JG Xie, D Brash, MT Huang, AH Conney: Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wildtype p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice. Cancer Res 60, 4785-4791 (2000)
94. J Liao, GY Yang, ES Park, X Meng, KKL Ho, D Jia, DN Seril, CS Yang: Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr Cancer 48(1), 44-53 (2004)
95. S Gupta, K Hastak, N Ahmad, JS Lewin, H Mukhtar: Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 8: 10350-10355 (2001)
96. VM Adhami, IA Siddiqui, N Ahmad, S Gupta, H Mukhtar: Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 64, 8715-8722 (2004)
97. WS Ahn, J Yoo, SW Huh, CK Kim, JM Lee, SE Namkoong, SM Bae, IP Lee: Protective effects of green tea extract (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev 12, 383-390 (2003)
98. A Jatoi, N Ellison, PA Burch, JA Sloan, SR Dakhil, P Novotny, W Tan, TR Fitch, KM Rowland, CY Young, PJ Flynn: A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97, 1442-1446 (2003)
99. W Jedrychowski, U Maugeri, T Popiela, J Kulig, E Sochacka-Tatara, A Pac, A Sowa, A Musial: Case-control study on beneficial effect of regular consumption of apples on colorectal cancer risk in a population with relatively low intake of fruits and vegetables. Eur J Cancer Prev 19(1), 42-47 (2010)
100. S Schaefer, M Baum, G Eisenbrand, C Janzowski: Modulation of oxidative cell damage by reconstituted mixtures of phenolic apple juice extracts in human colon cell lines. Mol Nutr Food Res 50(4-5), 413-417 (2006)
101. S Veeriah, C Miene, N Habermann, T Hofmann, S Klenow, J Sauer, F Böhmer, S Wölfl, BL Pool-Zobel. Apple polyphenols modulate expression of selected genes related to toxicological defence and stress response in human colon adenoma cells. Int J Cancer 122(12), 2647-2655 (2008)
102. A Petermann, C Miene, G Schulz-Raffelt, K Palige, J Hölzer, M Glei, FD Böhmer: GSTT2, a phase II gene induced by apple polyphenols, protects colon epithelial cells against genotoxic damage. Mol Nutr Food Res 53(10), 1245-1253 (2009)
103. M Ding, Y Lu, L Bowman, C Huang, S Leonard, L Wang, V Vallyathan, V Castranova, X Shi: Inhibition of AP-1 and neoplastic transformation by fresh apple peel extract. J Biol Chem 279(11), 10670-10676 (2004)
104. M Kern, Z Tjaden, Y Ngiewih, N Puppel, F Will, H Dietrich, G Pahlke, D Marko: Inhibitors of the epidermal growth factor receptor in apple juice extract. Mol Nutr Food Res 49(4), 317-328 (2005)
105. J Sun, RH Liu: Apple phytochemical extracts inhibit proliferation of estrogen-dependent and estrogenindependent human breast cancer cells through cell cycle modulation. J Agric Food Chem 56(24), 11661-11667 (2008)
106. H Yoon, RH Liu: Effect of selected phytochemicals and apple extracts on NF-kappaB activation in human breast cancer MCF-7 cells. J Agric Food Chem 55(8), 3167-3173 (2007)
107. X He, RH Liu: Triterpenoids isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple's anticancer activity. J Agric Food Chem 55(11), 4366-4370 (2007)
108. S Reagan-Shaw, D Eggert, H Mukhtar, N Ahmad: Antiproliferative effects of apple peel extract against cancer cells. Nutr Cancer 62(4), 517-524 (2010)
109. RH Liu, J Liu, B Chen: Apples prevent mammary tumors in rats. J Agric Food Chem 3(6), 2341-2343 (2005)
110. T Miura, M Chiba, K Kasai, H Nozaka, T Nakamura, T Shoji, T Kanda, Y Ohtake, T Sato: Apple procyanidins induce tumor cell apoptosis through mitochondrial pathway activation of caspase-3. Carcinogenesis 29(3), 585-593 (2008)
111. JR Liu, HW Dong, BQ Chen, P Zhao, RH Liu: Fresh apples suppress mammary carcinogenesis and proliferative activity and induce apoptosis in mammary tumors of the Sprague-Dawley rat. J Agric Food Chem 57(1), 297-304 (2009)
112. R Gayathri, DK Priya, GR Gunassekaran, D Sakthisekaran: Ursolic acid attenuates oxidative stressmediated hepatocellular carcinoma induction by diethylnitrosamine in male Wistar rats. Asian Pac J Cancer Prev 10(5), 933-938 (2009)
113. SW Barth, C Fähndrich, A Bub, H Dietrich, B Watzl, F Will, K Briviba, G Rechkemmer: Cloudy apple juice decreases DNA damage, hyperproliferation and aberrant crypt foci development in the distal colon of DMH-initiated rats. Carcinogenesis 26(8), 1414-1421 (2005)
114. F Gossé, S Guyot, S Roussi, A Lobstein, B Fischer, N Seiler, F Raul: Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcinogenesis 26(7), 1291-1295 (2005)
115. F Gossé, S Roussi, S Guyot, A Schoenfelder, A Mann, JP Bergerat, N Seiler, F Raul: Potentiation of apple procyanidintriggered apoptosis by the polyamine oxidase inactivator MDL 72527 in human colon cancer-derived metastatic cells. Int J Oncol 29(2), 423-428 (2006)
116. K Tazawa, H Okami, I Yamashita, Y Ohnishi, K Kobashi, M Fujimaki: Anticarcinogenic action of apple pectin on fecal enzyme activities and mucosal or portal prostaglandin E2 levels in experimental rat colon carcinogenesis. J Exp Clin Cancer Res 16(1)33-38 (1997)
117. H Ohkami, K Tazawa, I Yamashita, T Shimizu, K Murai, K Kobashi, M Fujimaki: Effects of apple pectin on fecal bacterial enzymes in azoxymethane-induced rat colon carcinogenesis. Jpn J Cancer Res 86(6), 523-529 (1995)
118. AW Hsing, GW Comstock, H Abbey, BF Polk: Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 82(11), 941-946 (1990)
119. E Giovannucci, A Ascherio, EB Rimm, MJ Stampfer, GA Colditz, WC Willett: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87(23), 1767-1776 (1995)
120. PH Gann, J Ma, E Giovannucci, W Willett, FM Sacks, CH Hennekens, MJ Stampfer: Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59(6), 1225-1230 (1999)
121. AR Kristal, JH Cohen: Invited commentary: tomatoes, lycopene, and prostate cancer: How strong is the evidence? Am J Epidemiol 151(2), 124-127 (2000)
122. D Casso, E White, RE Patterson, T Agurs-Collins, C Kooperberg, PS Haines: Correlates of serum lycopene in older women. Nutr Cancer 36(2): 163-169 (2000)
123. RM Tamimi, GA Colditz, SE Hankinson: Circulating carotenoids, mammographic density, and subsequent risk of breast cancer. Cancer Res 69(24), 9323-9329 (2009)
124. E Giovannucci, EB Rimm, Y Liu, MJ Stampfer, WC Willett. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94(5), 391-398 (2002)
125. MS Edinger, WJ Koff: Effect of the consumption of tomato paste on plasma prostate-specific antigen levels in patients with benign prostate hyperplasia. Braz J Med Biol Res 39(8), 1115-1119 (2006)
126. S Schwarz, UC Obermüller-Jevic, E Hellmis, W Koch, G Jacobi, HK Biesalski: Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr 138(1), 49-53 (2008)
127. H Wang, LK Leung: The carotenoid lycopene differentially regulates phase I and II enzymes in dimethylbenz[a]anthracene-induced MCF-7 cells. Nutrition [Epub ahead of print] (2010)
128. M Karas, H Amir, D Fishman, M Danilenko, S Segal, A Nahum, A Koifmann, Y Giat, J Levy, Y Sharoni: Lycopene interferes with cell cycle progression and insulinlike growth factor I signaling in mammary cancer cells. Nutr Cancer 36(1), 101-111(2000)
129. P Kanagaraj, MR Vijayababu, B Ravisankar, J Anbalagan, MM Aruldhas, J Arunakaran: Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-I receptor in prostate cancer cells. J Cancer Res Clin Oncol 133(6), 351-359 (2007)
130. LX Zhang, RV Cooney, JS Bertram: Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 12(11), 2109-2114 (1991)
131. H Salman, M Bergman, M Djaldetti, H Bessler. Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed Pharmacother 61(6), 366-369 (2007 Jul)
132. NI Ivanov, SP Cowell, P Brown, PS Rennie, ES Guns, ME Cox. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin Nutr 26(2), 252-263 (2007)
133. JS Bertram, A Pung, M Churley, TJ Kappock 4th, LR Wilkins, RV Cooney: Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis 12(4), 671-678 (1991)
134. K Forbes, K Gillette, I Sehgal: Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line: a brief communication. Exp Biol Med (Maywood) 228(8), 967-71 (2003)
135. J Talvas, C Caris-Veyrat, L Guy, M Rambeau, B Lyan, R Minet-Quinard, JM Lobaccaro, MP Vasson, S Georgé, A Mazur, E Rock: Differential effects of lycopene consumed in tomato paste and lycopene in the form of a purified extract on target genes of cancer prostatic cells. Am J Clin Nutr 91(6),1716-1724 (2010)
136. H Nagasawa, T Mitamura, S Sakamoto, K Yamamoto: Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res 15(4), 1173-1178 (1995)
137. HK Rooprai, M Christidou, GJ Pilkington: The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas. Acta Neurochir (Wien) 145(8), 683-690 (2003)
138. DJ Kim, N Takasuka, JM Kim, K Sekine, T Ota, M Asamoto, M Murakoshi, H Nishino, Z Nir, H Tsuda: Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett 120(1), 15-22. (1997)
139. E Okajima, M Tsutsumi, S Ozono, H Akai, A Denda, H Nishino, S Oshima, H Sakamoto, Y Konishi: Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroxybutyl)nitrosamine initiation. Jpn J Cancer Res 89(1), 22-26 (1998)
140. T Narisawa, Y Fukaura, M Hasebe, S Nomura, S Oshima, H Sakamoto, T Inakuma, Y Ishiguro, J Takayasu, H Nishino: Prevention of N-methylnitrosourea- induced colon carcinogenesis in F344 rats by lycopene and tomato juice rich in lycopene. Jpn J Cancer Res 89(10), 1003-1008 (1998)
141. T Narisawa, Y Fukaura, M Hasebe, M Ito, R Aizawa, M Murakoshi, S Uemura, F Khachik, H Nishino: Inhibitory effects of natural carotenoids, alpha-carotene, betacarotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett 107(1), 137-142 (1996)
142. MJ Wargovich, A Jimenez, K McKee, VE Steele, M Velasco, J Woods, R Price, K Gray, GJ Kelloff: Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21(6), 1149-1155 (2000)
143. P Astorg, S Gradelet, R Bergès, M Suschetet: Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr Cancer 29(1), 60-68 (1997)
144. L Chen, M Stacewicz-Sapuntzakis, C Duncan, R Sharifi, L Ghosh, R van Breemen, D Ashton, PE Bowen: Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 19; 93(24),1872-1879 (2001 Dec)
145. HS Kim, P Bowen, L Chen, C Duncan, L Ghosh, R Sharifi, K Christov: Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer 47(1), 40-47 (2003)
146. JK Campbell, CK Stroud, MT Nakamura, MA Lila, JW Erdman Jr: Serum testosterone is reduced following short-term phytofluene, lycopene, or tomato powder consumption in F344 rats. J Nutr 136(11), 2813-2819 (2006)
147. M Saleem, MH Kweon, JM Yun, VM Adhami, N Khan, DN Syed, H Mukhtar: A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgensensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res 65(23), 11203-11213 (2005)
148. L Zhang, Y Zhang, L Zhang, X Yang, Z Lv: Lupeol, a dietary triterpene, inhibited growth, and induced apoptosis through down-regulation of DR3 in SMMC7721 cells. Cancer Invest 27(2), 163-170 (2009)
149. S Prasad, N Nigam, N Kalra, Y Shukla: Regulation of signaling pathways involved in lupeol induced inhibition of proliferation and induction of apoptosis in human prostate cancer cells. Mol Carcinog 47(12), 916-924 (2008)
150. S Prasad, E Madan, N Nigam, P Roy, J George, Y Shukla: Induction of apoptosis by lupeol in human epidermoid carcinoma A431 cells through regulation of mitochondrial, Akt/PKB and NFkappaB signaling pathways. Cancer Biol Ther 8(17), 1632-6139 (2009)
151. M Saleem, N Maddodi, M Abu Zaid, N Khan, B bin Hafeez, M Asim, Y Suh, MYun J, V Setaluri, H Mukhtar: Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin Cancer Res 14(7),2119-2127 (2008)
152. M Saleem, I Murtaza, RS Tarapore, Y Suh, VM Adhami, JJ Johnson, IA Siddiqui, N Khan, M Asim, BB Hafeez, MT Shekhani, B Li, H Mukhtar: Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis 30(5),808-817 (2009)
153. M Saleem, I Murtaza, O Witkowsky, AM Kohl, N Maddodi: Lupeol triterpene, a novel diet-based microtubule targeting agent: disrupts survivin/cFLIP
154. TK Lee, RT Poon, JY Wo, S Ma, XY Guan, JN Myers, P Altevogt, AP Yuen: Lupeol suppresses cisplatininduced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. Cancer Res 67, 8800-8809 (2007)
155. N Nigam, S Prasad, J George, Y Shukla: Lupeol induces p53 and cyclin-B-mediated G2/M arrest and targets apoptosis through activation of caspase in mouse skin. Biochem Biophys Res Commun 381(2), 253-258 (2009)
156. S Prasad, N Kalra, M Singh, Y Shukla: Protective effects of lupeol and mango extract against androgen induced oxidative stress in Swiss albino mice. Asian J Androl 10(2), 313-318 (2008)
157. S Prasad, N Kalra, Y Shukla: Induction of apoptosis by lupeol and mango extract in mouse prostate and LNCaP cells. Nutr Cancer 60(1), 120-30 (2008)
158. N Nigam, K Bhui, S Prasad, J George, Y Shukla: [6]-Gingerol induces reactive oxygen species regulated mitochondrial cell death pathway in human epidermoid carcinoma A431 cells. Chem Biol Interact 181(1), 77-84 (2009)
159. N Nigam, J George, S Srivastava, P Roy, K Bhui, M Singh, Y Shukla: Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis. Cancer Chemother Pharmacol 65(4), 687-696 (2010)
160. YJ Park, J Wen, S Bang, SW Park, SY Song: [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med J 47(5), 688-697 (2006)
161. SH Lee, M Cekanova, SJ Baek: Multiple mechanisms are involved in 6- gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog 47, 197-208 (2008)
162. YL Hsu, CY Chen, MF Hou, EM Tsai, YJ Jong, CH Hung, PL Kuo: 6-Dehydrogingerdione, an active constituent of dietary ginger, induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun Nterminal kinase pathways in human breast cancer cells. Mol Nutr Food Res [Epub ahead of print] (2010)
163. YS Keum, J Kim, KH Lee, KK Park, YJ Surh, JM Lee, SS Lee, JH Yoon, SY Joo, IH Cha, JI Yook: Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells. Cancer Lett 177(1), 41-47 (2002)
164. Y Shukla, S Prasad, C Tripathi, M Singh, J George, N Kalra: In vitro and in vivo modulation of testosterone mediated alterations in apoptosis related proteins by [6]-gingerol. Mol Nutr Food Res 51, 1492-1502 (2007)
165. Pan MH, Hsieh MC, Kuo JM, Lai CS, Wu H, Sang S, Ho CT. 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol Nutr Food Res 52(5): 527-37. (2008)
166. SO Kim, KS Chun, JK Kundu, YJ Surh: Inhibitory effects of [6]-gingerly on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. Biofactors 21, 27-31 (2004)
167. SH Habib, S Makpol, NA Abdul Hamid, S Das, WZ Ngah, YA Yusof: Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionineinduced hepatoma rats. Clinics (Sao Paulo) 63(6), 807-813 (2008)
168. JY Hung, YL Hsu, CT Li, YC Ko, WC Ni, MS Huang, PL Kuo: 6-Shogaol, an Active Constituent of Dietary Ginger, Induces Autophagy by Inhibiting the AKT/mTOR Pathway in Human Non-Small Cell Lung Cancer A549 Cells. J Agric Food Chem [Epub ahead of print] (2009)
169. AM Bode, WY Ma, YJ Surh, Z Dong: Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res 61, 850-853 (2001)
170. EC Kim, JK Min, TY Kim, SJ Lee, HO Yang, S Han et a: [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 335, 300-308 (2005)
171. AC Brown, C Shah, J Liu, JT Pham, JG Zhang, MR Jadus: Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro. Phytother Res 23(5), 640-645 (2009)
172. SK Katiyar, R Agarwal, H Mukhtar: Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res 56(5), 1023-1030 (1996)
173. YJ Surh, KK Park, KS Chun, LJ Lee, E Lee, SS Lee: Anti-tumor-promoting activities of selected pungent phenolic substances present in ginger. J Environ Pathol Toxicol Oncol 18(2),131-139 (1999)
174. KK Park, KS Chun, JM Lee, SS Lee, YJ Surh: Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 129(2), 139-144 (1998)
175. SO Kim, JK Kundu, YK Shin, JH Park, MH Cho, TY Kim, YJ Surh: [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene 24(15), 2558-2567 (2005)
176. JK Kim, Y Kim, KM Na, YJ Surh, TY Kim: [6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radic Res 41(5), 603-614 (2007)
177. WY Chung, YJ Jung, YJ Surh, SS Lee, KK Park: Antioxidative and antitumor promoting effects of [6]-paradol and its homologs. Mutat Res 496(1-2), 199-206 (2001)
178. DJ Morre, PJ Chueh, DM Morre: Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci USA 92, 1831-1835 (1995)
179. DJ Morre, E Sun, C Geilen, LY Wu, R de Cabo, K Krasagakis CE Orfanos, DM Morré: Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur J Cancer 32A, 1995-2003 (1996)
180. SN Kang, SW Chung, TS Kim: Capsaicin potentiates 1, 25-dihydoxyvitamin D3- and all-trans retinoic acidinduced differentiation of human promyelocytic leukemia HL-60 cells. Eur J Pharmacol 420(2-3), 83-90 (2001)
181. J Zhang, M Nagasaki, Y Tanaka, S Morikawa: Capsaicin inhibits growth of adult T-cell leukemia cells. Leuk Res 27, 275-283 (2003)
182. JD Kim, JM Kim, JO Pyo, SY Kim, BS Kim, R Yu, IS Han: Capsaicin can alter the expression of tumor formingrelated genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett 120, 235-241 (1997)
183. A Mori, S Lehmann, J O′Kelly, T Kumagai, JC Desmond, M Pervan, WH McBride, M Kizaki, HP Koeffler: Capsaicin, a component of red peppers, inhibits the growth of androgen- independent, p53 mutant prostate cancer cells. Cancer Res 66, 3222-3229 (2006)
184. M Bhutani, AK Pathak, AS Nair, AB Kunnumakkara, S Guha, G Sethi, BB Aggarwal: Capsaicin is a novel blocker of constitutive and interleukin-6- inducible STAT3 activation. Clin Cancer Res 13, 3024-3032 (2007)
185. HM Wang, PJ Chueh, SP Chang, CL Yang, KN Shao: Effect of capsaicin on tNOX (ENOX2) protein expression in stomach cancer cells. Biofactors 34(3), 209-217 (2009)
186. ZH Yang, XH Wang, HP Wang, LQ Hu, XM Zheng, SW Li: Capsaicin mediates cell death in bladder cancer T24 cells through reactive oxygen species production and mitochondrial depolarization. Urology 75(3), 735-741 (2010)
187. NH Thoennissen, J O'Kelly, D Lu, GB Iwanski, DT La, S Abbassi, A Leiter, B Karlan, R Mehta, HP Koeffler: Capsaicin causes cell-cycle arrest and apoptosis in ERpositive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene 29(2), 285-296 (2010)
188. CS Kim, WH Park, JY Park, JH Kang, MO Kim, T Kawada, H Yoo, IS Han, R Yu: Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. J Med Food 7(3), 267-273 (2004)
189. HJ Kang, Y Soh, MS Kim, EJ Lee, YJ Surh, HR Kim, SH Kim, A Moon: Roles of JNK-1 and p38 in selective induction of apoptosis by capsaicin in ras-transformed human breast epithelial cells. Int J Cancer 103(4), 475-482 (2003)
190. Y-J Surh, SS Han, Y-S Keum, H-J Seo, SS Lee: Inhibitory effects of curcumin and capsaicin on phorbol ester-induced activation of eukaryotic transcription factors, NF-kB and AP-1. Biofactors 12,107-112 (2000)
191. S Singh, K Natarajan, BB Aggarwal: Capsaicin (8-methyl-N-vanillyl-6- nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. J Immunol 157, 4412-4420 (1996)
192. S Brar, TP Kennedy, AR Whorton, AB Sturrock, TP Huecksteadt, AJ Ghio, JR Hoidal: Reactive oxygen species from NAD(P)H: quinone oxidoreducase constitutively activate NF-kB in malignant melanoma cells. Am J Physiol Cell Physiol 280: C659-C676 (2001)
193. DH Shin, OH Kim, HS Jun, MK Kang: Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway. Exp Mol Med 40(5), 486-494 (2008)
194. AK De, JJ Ghosh: Studies on capsaicin inhibition of chemically-induced lipid peroxidation in the lung and liver tissues of rat. Phytotherapy Research 6, 34-37 (1992)
195. C Toskulkao, S Tekittipong: Capsaicin inhibits exercise induced lipid peroxidation in cardiac and skeletal muscles of rat. Phytotherapy Research 6: 34-37 (1996)
196. JY Kang, CT Teng, A Wee, FC Chen: Effect of capsaicin and chilli on ethanol induced gastric mucosal injury in the rat. Gut 36, 664-669 (1995)
197. JS Park, MA Choi, BS Kim, IS Han, T Kurata, R Yu: Capsaicin protects against ethanol-induced oxidative injury in the gastrointestinal mucosa of rats. Life Sciences 67, 3087-3093 (2000)
198. KK Park, YJ Surh: Effects of capsaicin on chemically induced two-stage mouse skin carcinogenesis. Cancer Lett 114, 183-184 (1997)
199. SS Han, YS Keum, HJ Seo, KS Chun, SS Lee, YJ Surh: Capsaicin suppresses phorbol ester-induced activation of NFkB/ Rel and AP-1 transcription factors in sedmis. Cancer Lett 164, 119-126 (2001)
200. R Zhang, I Humphreys, RP Sahu, Y Shi, SK Srivastava: In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis 13(12), 1465-1478 (2008)
201. P Anandakumar, S Kamaraj, S Jagan, G Ramakrishnan, C Naveenkumar, S Asokkumar, T Devaki: Capsaicin alleviates the imbalance in xenobiotic metabolizing enzymes and tumor markers during experimental lung tumorigenesis. Mol Cell Biochem 331(1-2), 135-143 (2009)
202. K Chobotova, AB Vernallis, FA Majid: Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives. Cancer Lett 290(2), 148-156 (2010)
203. SJ Taussig, S Batkin: Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application: An update. J Ethnopharmacol 22, 191-203 (1988)
204. G Gerard: [Anticancer treatment and bromelains]. Agressologie 13(4), 261-274 (1972)
205. SJ Taussig, J Szekerczes, S Batkin: Inhibition of Tumour Growth in vitro by Bromelain: an Extract of the Pineapple Plant (Ananas comosus). Planta Med 51(6), 538-539 (1985)
206. S Batkin, SJ Taussig, J Szekerezes: Antimetastatic effect of bromelain with or without its proteolytic and anticoagulant activity. J Cancer Res Clin Oncol 114, 507 (1988)
207. J Beuth, JM Braun: Modulation of murine tumor growth and colonization by bromelaine: an extract of the pineapple plant (Ananas comosum L.). In vivo 19(2), 483-485 (2005)
208. N Kalra, K Bhui, P Roy, S Srivastava, J George, S Prasad, Y Shukla: Regulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol Appl Pharmacol 226(1), 30-37 (2008)
209. K Bhui, S Prasad, J George, Y Shukla: Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway. Cancer Lett 282(2), 167-176 (2009)
210. K Eckert, E Grabowska, R Stange, U Schneider, K Eschmann, HR Maurer: Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients. Oncol Rep 6(6), 1191-1199 (1999)
211. E Skrzypczak-Jankun, K Zhou, NP McCabe, SH Selman, J Jankun: Structure of curcumin in complex with lipoxygenase and its significance in cancer. Int J Mol Med 12, 17-24 (2003)
212. BB Aggarwal, A Kumar, AC Bharti: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398 (2003)
213. BK Prusty, BC Das: Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 113(6), 951-960 (2005)
214. CS Divya, MR Pillai: Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 45(5), 320-332 (2006)
215. S Singh, BB Aggarwal: Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270, 24995-25000 (1995)
216. W Hartojo, AL Silvers, DG Thomas, CW Seder, L Lin, H Rao, Z Wang, JK Greenson, TJ Giordano, MB Orringer, A Rehemtulla, MS Bhojani, DG Beer, AC Chang: Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl Oncol 3(2), 99-108 (2010)
217. A Singh, SP Singh, R Bamezai: Postnatal modulation of hepatic biotransformation system enzymes via translactational exposure of F1 mouse pups to turmeric and curcumin. Cancer Lett 96(1), 87-93 (1995)
218. MT Huang, T Lusz, T Ferraro, TF Abidi, JD Laskin, AH Conney: Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Research 51, 813-819 (1991)
219. Z Wang, Y Zhang, S Banerjee, Y Li, FH Sarkar: Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 106(11), 2503-2513 (2006)
220. AC Bharti, N Donato, BB Aggarwal: Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171, 3863-3871 (2003)
221. MS Squires, EA Hudson, L Howells, S Sale, CE Houghton, JL Jones, LH Fox, M Dickens, SA Prigent, MM Manson: Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol 65(3), 361-376 (2003)
222. G Chadalapaka, I Jutooru, S Chintharlapalli, S Papineni, R Smith 3rd, X Li, S Safe: Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res 68(13), 5345-5354 (2008)
223. X Gao, D Deeb, H Jiang, YB Liu, SA Dulchavsky, SC Gautam: Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. J Exp Ther Oncol 5(1), 39-48 (2005)
224. YP Lu, RL Chang, MT Huang, AH Conney: Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol- 13-acetateinduced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14, 293-297 (1993)
225. MT Huang, W Ma, P Yen, JG Xie, J Han, K Frenkel, D Grunberger, AH Conney: Inhibitory effects of topical application of low doses of curcumin on 12-Otetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis 18, 83-88 (1997)
226. TS Huang, SC Lee, JK Lin: Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proceedings of the National Academy of Sciences of the USA 88, 5292-5296 (1991)
227. SS Kakar, D Roy: Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett 87, 85-89 (1994)
228. CV Rao, A Rivenson, B Simi, BS Reddy: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55(2), 259-266 (1995)
229. A Bierhaus, Y Zhang, P Quehenberger, T Luther, M Haase, M Müller, N Mackman, R Ziegler, PP Nawroth: The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost 77(4), 772-782 (1997)
230. JC Lee, PA Kinniry, E Arguiri, M Serota, S Kanterakis, S Chatterjee, CC Solomides, P Javvadi, C Koumenis, KA Cengel, M Christofidou-Solomidou: Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res 173(5), 590-601 (2010)
231. A Goel, AB Kunnumakkara, BB Aggarwal: Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 75, 787-809 (2008)
232. DS Michaud, D Spiegelman, SK Clinton, EB Rimm, WC Willett, EL Giovannucci: Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 91, 605-613 (1999)
233. SJ London, J-M Yuan, FL Chung, YT Gao, GA Coetzee, MC Yu, RK Ross: Isothiocyanates, glutathione Stransferase M1 and T1 polymorphisms and lung cancer risk: a prospective study of men in Shanghai, China. Lancet 356, 724-729 (2000)
234. MC Bell, P Crowley-Nowick, HL Bradlow, DW Sepkovic, D Schmidt-Grimminger, P Howell, EJ Mayeaux, A Tucker, EA Turbat-Herrera, JM Mathis: Placebocontrolled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 78, 123-129 (2000)
235. M Stanley: Chapter 17: Genital human papillomavirus infections - current and prospective therapies. J Natl Cancer Inst Monogr 117-124 (2003)
236. GA Reed, KS Peterson, HJ Smith, JC Gray, DK Sullivan, MS Mayo, JA Crowell, A Hurwitz: A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 14(8), 1953-1960 (2005)
237. FA Fares, X Ge, S Yannai, G Rennert: Dietary indole derivatives induce apoptosis in human breast cancer cells. Adv Exp Med Biol 451, 153-157 (1998)
238. CM Cover, SJ Hsieh, SH Tran, G Hallden, GS Kim, LF Bjeldanes, GL Firestone: Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 273, 3838-3847 (1998)
239. SR Chinni, Y Li, S Upadhyay, PK Koppolu, FH Sarkar: Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20(23), 2927-2936 (2001)
240. DZ Chen, M Qi, KJ Auborn, TH Carter: Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. J Nutr 131, 3294-3302 (2001)
241. M Nachshon-Kedmi, S Yannai, A Haj, FA Fares: Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 41, 745-752 (2003)
242. G Brandi, M Paiardini, B Cervasi, C Fiorucci, P Filippone, C De Marco, N Zaffaroni, M Magnani: A new indole-3-carbinol tetrameric derivative inhibits cyclindependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines. Cancer Res 63, 4028-4036 (2003)
243. GL Firestone, LF Bjeldanes: Indole-3-carbinol and 3-3′- diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr 133 (7 Suppl.), 2448S-255S (2003)
244. HS Choi, MC Cho, HG Lee, DY Yoon: Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells. Food Chem Toxicol 48(3), 883-890 (2010)
245. KW Rahman, Y Li, FH Sarkar: Inactivation of Akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 48, 84-94 (2004)
246. I Aronchik, LF Bjeldanes, GL Firestone: Direct inhibition of elastase activity by indole-3-carbinol triggers a CD40-TRAF regulatory cascade that disrupts NF-kappaB transcriptional activity in human breast cancer cells. Cancer Res 70(12), 4961-4971 (2010)
247. CT Brew, I Aronchik, JC Hsu, JH Sheen, RB Dickson, LF Bjeldanes, GL Firestone: Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells. Int J Cancer 118(4), 857-868 (2006)
248. Q Meng, F Yuan, ID Goldberg, EM Rosen, K Auborn, S Fan: Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J Nutr 130, 2927-2931 (2000)
249. BT Ashok, Y Chen, X Liu, HL Bradlow, A Mittelman, RK Tiwari: Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol. Nutr Cancer 41, 180-187 (2001)
250. SN Sundar, V Kerekatte, CN Equinozio, VB Doan, LF Bjeldanes, GL Firestone: Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells. Mol Endocrinol 20(12), 3070-3082 (2006)
251. J Zhang, B A JC Hsu, B A MA Kinseth, LF Bjeldanes, GL Firestone: Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells. Cancer 98(11), 2511-2520 (2003)
252. JC Hsu, J Zhang, A Dev, A Wing, LF Bjeldanes, GL Firestone: Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells. Carcinogenesis 26(11), 1896-1904 (2005)
253. CN Marconett, SN Sundar, KM Poindexter, TR Stueve, LF Bjeldanes, GL Firestone: Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER) alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop. Mol Biol Cell 21(7), 1166-1177 (2010)
254. WC Hung, HC Chang: Indole-3-carbinol inhibits Sp1-induced matrix metalloproteinase-2 expression to attenuate migration and invasion of breast cancer cells. J Agric Food Chem 57(1), 76-82 (2009)
255. A Arora, Y Shukla: Modulation of vinca-alkaloid induced P-glycoprotein expression by indole-3-carbinol. Cancer Lett. 189, 167-173 (2003)
256. JG Christensen, GA LeBlanc: Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol. Cancer Res 56, 574-581 (1996)
257. L Jin, M Qi, DZ Chen, A Anderson, GY Yang, JM Arbeit, KJ Auborn: Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res 59(16), 3991-3997 (1999)
258. HL Bradlow: Review: Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer. In vivo 22(4), 441-445 (2008)
259. S Donald, RD Verschoyle, P Greaves, T Colombo, M Zucchetti, C Falcioni, M Zaffaroni, M D'Incalci, MM Manson, J Jimeno, WP Steward, AJ Gescher: Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma. Int J Cancer 111(6), 961-967 (2004)
260. A García, AI Haza, N Arranz, J Rafter, P Morales: Protective effects of isothiocyanates alone or in combination with vitamin C towards N-nitrosodibutylamine or Nnitrosopiperidine-induced oxidative DNA damage in the single-cell gel electrophoresis (SCGE)/HepG2 assay. J Appl Toxicol 28(2), 196-204 (2008)
261. M Qi, AE Anderson, DZ Chen, S Sun, KJ Auborn: Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo. Mol Med 11(1-12), 59-63 (2005)
262. TL Horn, MA Reichert, RL Bliss, D Malejka-Giganti: Modulations of P450 mRNA in liver and mammary gland and P450 activities and metabolism of estrogen in liver by treatment of rats with indole-3-carbinol. Biochem Pharmacol 64(3), 393-404 (2002)
263. F Kassie, I Matise, M Negia, P Upadhyaya, SS Hecht: Dose-dependent inhibition of tobacco smoke carcinogeninduced lung tumorigenesis in A/J mice by indole-3-carbinol. Cancer Prev Res (Phila Pa) 1(7), 568-576 (2008)
264. F Kassie, S Kalscheuer, I Matise, L Ma, T Melkamu, P Upadhyaya, SS Hecht: Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myoinositol in A/J mice. Carcinogenesis 31(2), 239-245 (2010)
265. N Shimano, N Uehara, Y Kiyozuka, N Shikata, A Tsubura: Effects of prepubertal indole-3-carbinol treatment on development of N-methyl-N- nitrosourea-induced mammary carcinomas in female Sprague-Dawley rats. In vivo 21(6), 983-988 (2007)
266. MM Bhuiyan, Y Li, S Banerjee, F Ahmed, Z Wang, S Ali, FH Sarkar: Down-regulation of androgen receptor by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Res 66(20), 10064-10072 (2006)
267. Y Li, Z Wang, D Kong, S Murthy, QP Dou, S Sheng, GP Reddy, FH Sarkar: Regulation of FOXO3a/betacatenin/GSK-3beta signaling by 3,3′- diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 282(29), 21542-21550 (2007)
268. I Chen, A McDougal, F Wang, S Safe: Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19(9), 1631-1639 (1998)
269. EJ Kim, SY Park, HK Shin, DY Kwon, YJ Surh, JH Park: Activation of caspase-8 contributes to 3,3′-Diindolylmethane-induced apoptosis in colon cancer cells. J Nutr 137(1), 31-36 (2007)
270. VP Garikapaty, BT Ashok, K Tadi, A Mittelman, RK Tiwari: 3,3′-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun 340(2), 718-725 (2006)
271. CJ Grubbs, VE Steele, T Casebolt, MM Juliana, I Eto, LM Whitaker, KH Dragnev, GJ Kelloff, RL Lubet: Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15, 709-716 (1995)
272. TTY Wang, MJ Milner, YS Kim: Identification of estrogen receptor alpha as a gene down regulated by indole-3-carbinol in human breast cancer cell MCF-7: a cDNA microarray approach. Proceedings; Frontier in Cancer Prevention Research (Oct 14-18, 2002, Boston MA), 150 (2002)
273. BT Ashok, YG Chen, X Liu, VP Garikapaty, R Seplowitz, J Tschorn, K Roy, A Mittelman, RK Tiwari: Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer. Eur J Cancer Prev 11 (Suppl 2), S86-S93 (2002)
274. H Leong, JE Riby, GL Firestone, LF Bjeldanes: Potent ligand-independent estrogen receptor activation by 3,3′-di-indolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways. Mol Endocrinol 18, 291-302 (2004)
275. H Leong, GL Firestone, LF Bjeldanes: Cytostatic effects of 3,3′-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression. Carcinogenesis 22, 1809-1817 (2001)
276. KM Rahman, S Ali, A Aboukameel, SH Sarkar, Z Wang, PA Philip, WA Sakr, A Raz: Inactivation of NFkappaB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Mol Cancer Ther 6(10), 2757-2765 (2007)
277. X Chang, JC Tou, C Hong, HA Kim, JE Riby, GL Firestone, LF Bjeldanes: 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26(4), 771-778 (2005)
278. EJ Kim, M Shin, H Park, JE Hong, HK Shin, J Kim, DY Kwon, JH Park: Oral administration of 3,3′-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. J Nutr 139(12), 2373-2379 (2009)
279. AJ Tuyns: Protective effect of citrus fruit on esophageal cancer. Nutrition and Cancer 5, 195-200 (1983)
280. C Bosetti, S Gallus, A Trichopoulou, R Talamini, S Franceschi, E Negri, C La Vecchia: Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 12(10), 1091-1094 (2003)
281. G Launoy, C Milan, NE Day, MP Pienkowski, M Gignoux, J Faivre: Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int J Cancer 76(1), 7-12. (1998)
282. IA Hakim, RB Harris, C Ritenbaugh. Citrus peel use is associated with reduced risk of squamous cell carcinoma of the skin. Nutr Cancer 37(2), 161-168 (2000)
283. Q Tian, EG Miller, H Ahmad, L Tang, BS Patil: Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer 40(2), 180-184 (2001)
284. PL Crowell: Prevention and therapy of cancer by dietary monoterpenes. J Nutr: 129,775S-778S (1999)
285. N Uedo, M Tatsuta, H Iishi, et al: Inhibition by dlimonene of gastric carcinogenesis induced by N-methyl-N'-nitro-Nnitrosoguanidine in Wistar rats. Cancer Lett 137,131-136 (1999)
286. H Yano, M Tatsuta, H Iishi, et al: Attenuation by dlimonene of sodium chloride-enhanced gastric carcinogenesis induced by N-methyl-N'-nitro-N- nitrosoguanidine in Wistar rats. Int J Cancer 82,665-668 (1999)
287. EM Van der Logt, HM Roelofs, EM van Lieshout, FM Nagengast, WH Peters: Effects of dietary anticarcinogens and nonsteroidal anti-inflammatory drugs on rat gastrointestinal UDP-glucuronosyltransferases. Anticancer Res 24(B), 843-849 (2004)
288. SD Hursting, SN Perkins, DC Haines, JM Ward, JM Phang: Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res 55, 3949-3953 (1995)
289. JA Elegbede, CE Elson, A Qureshi, MA Tanner, MN Gould: Inhibition of DMBA induced mammary cancer by the monoterpene d-limonene. Carcinogenesis 5, 661-664 (1984)
290. CE Elson, TH Maltzman, JL Boston, MA Tanner, MN Gould: Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis. Carcinogenesis 9,331-332 (1988)
291. TH Maltzman, LM Hurt, CE Elson, MA Tanner, MN Gould: The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil. Carcinogenesis 10, 781-783 (1989)
292. LW Wattenberg: Inhibition of neoplasia by minor dietary constituents. Cancer Res 43, 2448S-2453S (1983)
293. J A Elegbede, CE Elson, MA Tanner, A Qureshi, MN Gould: Regression of rat primary mammary tumors following dietary d-limonene. J Natl Cancer Inst 76, 323-325 (1986)
294. DR Dietrich, JA Swenberg: The presence of alpha 2uglobulin is necessary for d-limonene promotion of male rat kidney tumors. Cancer Res 51, 3512-3521 (1991)
295. LW Wattenberg, VL Sparnins, G Barany: Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes. Cancer Res 49, 2689-2692 (1989)
296. LW Wattenberg, JB Coccia: Inhibition of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone carcinogenesis in mice by d-limonene and citrus fruit oils. Carcinogenesis 12, 115-117 (1991) 296.
297. MN Gould, CJ Moore, R Zhang, B Wang, WS Kennan, JD Haag: Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras. Cancer Res 54, 3540-3543 (1994)
298. T Kawamori, T Tanaka, Y Hirose, M Ohnishi, H Mori: Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Carcinogenesis 17, 369-372 (1996)
299. EG Miller, R Fanous, F Rivera-Hidalgo, WH Binnie, S Hasegawa, LK Lam: The effect of citrus limonoids on hamster buccal pouch carcinogenesis. Carcinogenesis 10(8), 1535-1537 (1989)
300. T Ariyoshi, M Arakaki, K Ideguchi, Y Ishizuka, K Noda: Studies on the metabolism of d-Limonene (p-Mentha-1,8-diene). III. Effects of d-Limonene on the lipids and drugmetabolizing enzymes in rat livers. Xenobiotica 5(1), 33-38 (1975)
301. TH Maltzman, M Christou, MN Gould, CR Jefcoate: Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes. Carcinogenesis 12(11), 2081-2087 (1991)
302. RK Giri, T Parija, BR Das: D-limonene chemoprevention of hepatocarcinogenesis in AKR mice: inhibition of c-jun and c-myc. Oncol Rep 6, 1123-1127 (1999)
303. I Kaji, M Tatsuta, H Iishi, M Baba, A Inoue, H Kasugai: Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association. Int J Cancer 93, 441-444 (2001)
304. Norman: University of Oklahoma Press.Nunn J. Ancient Egyptian medicine p. 1-240 (1996)
305. AS Weisberger, J Pensky: Tumor inhibition by a sulfhydryl-blocking agent related to an active principle of garlic (Allium sativum). Cancer Res18, 1301-1308 (1958)
306. KA Steinmetz, LH Kushi, RM Bostick, AR Folsome, JD Potter: Vegetables, fruit and colon cancer in the Iowa Women's Health Study. Am J Epidemiol 139, 1-15 (1994)
307. E Dorant, PA van den Brandt, RA Goldbohm, RJ Hermus, F Sturmans: Garlic and its significance for the prevention of cancer in humans: a critical review. Br J Cancer 67, 424-429 (1993)
308. TJ Key, PB Silcocks, GK Davey, PN Appleby, DT Bishop. A case-control study of diet and prostate cancer. Br J Cancer 76, 678-687 (1997)
309. AW Hsing, AP Chokkalingam, YT Gao, MP Madigan, J Deng, G Gridley, JF Fraumeni Jr: Allium vegetables and risk of prostate cancer: a population-based
310. JT Pinto, RS Rivlin: Antiproliferative effects of allium derivatives from garlic. J Nutr 131, 1058S-1060S (2001)
311. R Munday, CM Munday: Relative activities of organosulfur compounds derived from onions and garlic in increasing tissue activities of quinine reductase and glutathione transferase in rat tissues. Nutr Cancer 40, 205-210 (2001)
312. H Nakagawa, K Tsuta, K Kiuchi, H Senzaki, K Tanaka, K Hioki, A Tsubura: Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 22, 891-897 (2001)
313. K Hirsch, M Danilenko, J Giat, T Miron, A Rabinkov, M Wilchek, D Mirelman, J Levy, Y Sharoni: Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer 38, 245-254 (2000)
314. K El-Bayoumy, Y Chae, P Upadhyaya, C Ip: Chemoprevention of mammary cancer by diallyl selenide, a novel organoselenium compound. Anticancer Res 16, 2911-2915 (1996)
315. K EI-Bayoumy: Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials. Carcinogenesis 15, 2395-2420 (1994)
316. H Sumiyoshi, MJ Wargovich: Chemoprevention of 1,2-dimethylhydrazine- induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Res 50, 5084-5087 (1990)
317. AK Maurya, SV Singh: Differential induction of glutathione transferase isoenzymes of mice stomach by diallyl sulfide, a naturally occurring anticarcinogen. Cancer Lett 57, 121-129 (1991)
318. CS Yang, SK Chhabra, JY Hong, TJ Smith: Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. J Nutr 131,1041s-1045s (2001)
319. S Shrotriya, JK Kundu, HK Na, YJ Surh: Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling. Cancer Res 70(5), 1932-1940 (2010)
320. VL Sparnins, G Barany, LW Wattenberg: Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione Stransferase activity in the mouse. Carcinogenesis 9(1), 131-134 (1988)
321. MJ Wargovich, C Woods, VW Eng, LC Stephens, K Gray: Chemoprevention of N-nitrosomethylbenzylamineinduced esophageal cancer in rats by the naturally occurring thieother, diallyl sulfide. Cancer Res 48, 6872-6875 (1988)
322. MJ Wargovich: Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis 8,487-489 (1987)
323. A Singh, A Arora, Y Shukla: Modulation of altered hepatic foci induction by diallyl sulphide in Wistar rats. Eur J Cancer Prev 13(4), 263-269 (2004)
324. SV Singh, SS Pan, SK Srivastava, H Xia, X Hu, HA Zaren, JL Orchard: Differential induction of NAD(P)H:quinone oxidoreductase by anti-carcinogenic organosulfides from garlic. Biochem Biophys Res Commun 244(3), 917-920 (1998)